China Resources Double-Crane Pharmaceutical Co.,Ltd. Stock
Stocks
600062
CNE000000Q94
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
06/11/2026
|
5-day change | 1st Jan Change | ||
| 16.07 CNY | -0.19% |
|
+5.93% | -12.14% |
| 04:26pm | CR Double-Crane Pharmaceutical Passes Drug GMP Compliance Inspection | MT |
| 04/11 | CR Double-Crane Pharmaceutical Gets Registration Certificates for Three Drugs | MT |
| Market Cap | 16.6B 2.49B 2.23B 2.04B 1.86B 3.5B 234B 3.61B 24.55B 9.79B 125B 9.33B 9.13B 394B | P/E 2026 * |
9.89x | P/E 2027 * | 9.24x |
|---|---|---|---|---|---|
| Enterprise Value | 16.6B 2.49B 2.23B 2.04B 1.86B 3.5B 234B 3.61B 24.55B 9.79B 125B 9.33B 9.13B 394B | EV / Sales 2026 * |
1.53x | EV / Sales 2027 * | 1.45x |
| Free-Float |
37.31% | Yield 2026 * |
2.86% | Yield 2027 * | 2.99% |
| 1 day | -0.19% | ||
| 1 week | +5.93% | ||
| Current month | +4.42% | ||
| 1 month | -1.05% | ||
| 3 months | -0.68% | ||
| 6 months | -9.97% | ||
| Current year | -12.14% |
| 1 week | 15.34 |  | 16.34 |
| 1 month | 15.03 | | 16.66 |
| Current year | 15.03 | | 19.08 |
| 1 year | 15.03 | | 19.77 |
| 3 years | 15.03 | | 26.15 |
| 5 years | 11.29 | | 37.44 |
| 10 years | 10.66 | | 37.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wen Hao Huang
DFI | Director of Finance/CFO | 43 | 18/02/2025 |
Qian Zhao
PSD | President | 45 | 25/10/2024 |
Li Hong Zheng
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ning Liu
BRD | Director/Board Member | 68 | 30/05/2006 |
Mao Zhu Sun
BRD | Director/Board Member | 67 | 12/07/2021 |
Shu Tian Yu
BRD | Director/Board Member | 60 | 10/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/12/22 | Buy | Chairman | 5,000 | 0.0005% | ||
| 21/12/22 | Buy | Director | 10,000 | 0.0010% | ||
| 20/12/22 | Buy | Director | 5,000 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.19% | +5.93% | -16.48% | -2.67% | 2.49B | |
| -0.03% | -3.68% | +45.65% | +129.40% | 1,216B | |
| +0.48% | +0.13% | +46.31% | +80.33% | 656B | |
| +0.65% | -1.85% | +32.14% | +104.98% | 509B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 384B | |
| -0.14% | -1.88% | +71.03% | +40.61% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 311B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 293B | |
| -0.11% | -1.20% | +45.89% | +68.76% | 249B | |
| +0.03% | -1.61% | +36.08% | +106.96% | 208B | |
| Average | -0.21% | +0.78% | +34.69% | +68.65% | 419.03B | |
| Weighted average by Cap. | -0.09% | +0.04% | +42.23% | +88.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.87B 1.63B 1.46B 1.33B 1.22B 2.29B 153B 2.37B 16.08B 6.41B 81.62B 6.11B 5.98B 258B | 11.45B 1.71B 1.54B 1.4B 1.28B 2.42B 161B 2.49B 16.93B 6.75B 85.96B 6.43B 6.29B 271B |
| Net income | 1.69B 253M 227M 207M 189M 356M 23.75B 367M 2.5B 995M 12.67B 948M 928M 40B | 1.81B 270M 242M 222M 202M 381M 25.41B 393M 2.67B 1.07B 13.56B 1.01B 993M 42.81B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | CNY 16.07 | -0.19% | 4,640,216 |
| 05/11/26 | CNY 16.10 | -0.19% | 6,346,646 |
| 04/11/26 | CNY 16.13 | +0.25% | 10,863,700 |
| 03/11/26 | CNY 16.09 | +2.55% | 10,278,764 |
| 02/11/26 | CNY 15.69 | +1.95% | 10,005,532 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600062 Stock
Select your edition
All financial news and data tailored to specific country editions
